Today’s AI Top Pick: ADMA

7/2/2026 · Short-Term Bounce 🧪 <= 20 screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Short-Term Bounce 🧪 <= 20ADMABUY NOW8.7 / 107/2/2026

ADMA is the cleanest setup in this pool by a wide margin. It shares the top screen score (15.5) with QFIN but with materially better tape context: bullish_prob = 1.0, near_term_bullish = 1.0, and the multi-timeframe forecast stack is uniformly positive — 1h fc_mid +11.33%, 4h fc_mid +77.27% and fc_long +108.39%, 1d fc_short +57.35% / fc_mid +62.32% / fc_long +47.35%, and 1wk fc_long +31.75%. Every horizon points the same direction, which is exactly the multi-timeframe agreement we want. Critically, ADMA is NOT chased. On the weekly it sits at just 8.73% of its 21-bar range with a -46.05% recent_21bar_pct — meaning we're buying deep in a longer-term drawdown while the intraday tape (77% of 1h range, 70% of 4h range) confirms an accumulation base. Contrast that with QFIN, HBAN, FNB, SAN, NWG, LYG, FLYW — all pinned at 100% of range on multiple timeframes with negative forward forecasts (SAN 1wk fc_long -40.83%, VLY 1d fc_short -24.42%). Those are late; ADMA is early. The fundamentals reinforce the trade. PE 12.7, fwdPe 8.94, PEG 0.31, ROE 43.3, operating margin 40.57%, profit margin 32.43%, debt/eq 0.52, salesYoY +10.99%, epsNextY +18.43%, analyst recom 1.75, and a monster targetUpsidePct of +106.2%. The YTD/1yr performance (-52%) explains why the screen flagged it as a short-term bounce candidate — it's a beaten-down high-quality profitable biotech that the forecast tape is now saying has reversed. News check: recent headlines are neutral-to-mildly-constructive (mentioned in a 'Biotech Firms With Major Potential Catalysts' piece June 21). No guidance cut, no legal action, no dilution, no short-seller report. This is the rare setup where fundamentals, multi-timeframe forecasts, position in range, and news all align. Waiting risks missing the base breakout — the daily is already at 92% of range with fc_short +57%, meaning today is the entry before the daily leg extends.

Entry zone

$8.40–$8.75 (current $8.68, add into any dip toward $8.40 which is the 4h base)

Stop loss

$7.80 (below 1h/4h drawdown floor, -10% risk)

First target

$10.50 (aligns with 1d fc_mid ~+20%)

Longer target

$14.00–$16.00 (aligns with 4h fc_long +108% and analyst target upside 106%)

Risks

1wk recent_21bar_pct is -46.05% — this is a knife-catch trade; if $7.80 breaks, structural downtrend resumes
Short float 9.45% — can amplify moves in both directions
Biotech single-name binary risk (plasma supply, IVIG pricing, FDA/regulatory headlines) — no catalyst is telegraphed but sector is event-driven
1h fc_short is -5.71%, suggesting intraday chop before the larger move — don't get shaken out
perfYear -51.85% shows persistent institutional selling; a failed bounce here would confirm distribution

Honorable mentions

CPNGbullish_prob 1.0, near_term 0.8, 4h fc_long +48.13% and 1d fc_mid +26.23%, sits at only 45.96% of weekly range (-16% dd) so not chased; South Korea/US political headline is a minor overhang but doesn't break the thesis

LYFTnear_term 0.8, PE 2.08, fwdPe 14.78, 4h fc_long +38.91% and 1wk fc_long +45.23%; downside is 25.59% short float and negative operating margin, but the tape is clearly turning

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	ADMA	BUY NOW	8.7	Bullish_prob 1.0, all four timeframes forecasting up, deep in weekly drawdown at 8.7% of range — textbook bounce setup with clean fundamentals.
2	CPNG	BUY NOW	7.4	1.0 bullish_prob, 0.8 near-term, 4h fc_long +48% and 1wk fc_mid +32%, not extended (46% of weekly range).
3	LYFT	BUY PULLBACK	6.8	Cheap (PE 2.08), 4h/1wk long forecasts +38%/+45%, but at 97% of weekly range — wait for a dip toward $14.
4	QFIN	BUY PULLBACK	6.5	Killer fundamentals (PE 3, ROE 21) and 1wk fc_long +88%, but pinned at 100% of range on every timeframe — chase risk high; buy the pullback.
5	RNW	WAIT	5.6	Analyst upgrade tailwind and 1wk fc_long +7.47%, but mid-term forecasts negative across 1h/4h/1d.
6	DNOW	BUY PULLBACK	5.4	At 0% of range across 1h/4h/1d with positive forecasts on all horizons — legit oversold bounce, but low near-term probability.
7	GRND	WAIT	4.5	Morgan Stanley upgrade is positive but all forecast horizons negative and RSI 76 at 100% of range — too extended.
8	SOFI	WAIT	4.3	4h fc_long +57% is intriguing but 1wk fc_mid -33% and pinned at 100% of range short-term.
9	FRMI	WAIT	4.0	AI-narrative Fermi story, but no bullish_prob, 4h fc_long +27% offset by 1d/1h fc_mid deeply negative.
10	AUPH	WAIT	3.9	At 0-7% of 1h/4h/1d range but every forecast horizon beyond fc_short is negative (1wk fc_long -35%).
11	BGC	WAIT	3.7	Q2 sales guidance affirmed positive, but 4h dd -15% and forecasts mostly negative beyond fc_short.
12	BCRX	AVOID	3.5	Just announced discontinuation of internal discovery programs — material negative headline overriding a decent forecast.
13	HBAN	AVOID	3.3	Fundamental_score 8 but at 100% of range every timeframe with all forecasts negative (1wk fc_long -24%).
14	PAYO	AVOID	3.2	Two recent broker downgrades (Benchmark, Citi) and RSI 76.73 at 98% of range with fc_long -28%.
15	FNB	AVOID	3.1	100% of range, RSI 70, and 1wk fc_long -26% — screen match but tape rolling over.
16	NWG	AVOID	3.0	1wk fc_long -37.97% at 100% of range — buying the top of a rate-driven rally.
17	VLY	AVOID	2.9	1d fc_short -24% and 1wk fc_long -37% at 97% of range — analyst price bumps not enough.
18	LYG	AVOID	2.8	100% of range on every timeframe with 1wk fc_long -33% — Halifax rebrand headlines are neutral at best.
19	SGHC	AVOID	2.6	Bullish_prob 0, all forecasts red across the board (1wk fc_mid -60%), at 100% of range.
20	AEG	AVOID	2.5	Every forecast horizon negative, 1wk fc_mid -39%, at 100% of range.
21	GENB	WAIT	2.4	Limited data (only 1h available), fc_long -18.83% — insufficient conviction.
22	SAN	AVOID	2.3	1wk fc_long -40.83% at 100% of range — mega-cap Euro bank topped out.
23	DHT	AVOID	2.2	1wk fc_long -37.5% and epsNextY -41% — tanker peak fading.
24	BBAR	AVOID	2.1	1wk fc_long -49.97%, PEG 0.17 offset by macro Argentina risk and deteriorating forecasts.
25	MFG	AVOID	2.0	1wk fc_mid -49.53%, 1d fc_short -19% — Japanese mega-bank rolling over.
26	FLYW	AVOID	1.9	Insider selling flagged, RSI 73, at 100% of range with 1d fc_mid -25%.
27	AMRX	AVOID	1.6	1wk fc_long -59.48%, RSI 72.87, targetUpsidePct just +1.6% — party over.
28	AAL	AVOID	1.5	RSI 79, all forecasts sharply negative (fc_mid -32%), analyst target upside -4.2%.
29	FA	AVOID	1.3	PE 388, target upside -4%, RSI 73.7 — 'overrated stock' StockStory piece confirms.
30	NWBI	AVOID	1.2	RSI 71, recom 2.75, targetUpsidePct -2.3%, StockStory 'reasons to sell' piece.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord